Stocks and Investing Stocks and Investing
Tue, May 31, 2022

Raghuram Selvaraju Maintained (ADXN) at Strong Buy with Decreased Target to $300 on, May 31st, 2022


Published on 2024-10-27 21:21:39 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "Addex Therapeutics Ltd" (ADXN) at Strong Buy with Decreased Target from $420 to $300 on, May 31st, 2022.

Raghuram, nor any peers, have made any analyst calls on ADXN in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources